Compare Bio Protocol (BIO) vs Resolv (RESOLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Resolv — how do they compare? Bio Protocol trades at Rp489.52 (market cap Rp1,1T, Rp300,74M 24h volume), while Resolv trades at Rp351.07 (market cap Rp151,33M, Rp133,93M 24h volume). The key difference: Bio Protocol is far larger — about 7268.9× Resolv's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 429,5M / 1B RESOLV (43%) for Resolv. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Resolv for 7 Days on average.
| BIO | RESOLV | |
|---|---|---|
Market Cap | Rp1,1T | Rp151,33M |
Volume (24h) | Rp300,74M | Rp133,93M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 429,5M / 1B RESOLV (43%) |
Typical Hold Time | 16 Days | 7 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Resolv (RESOLV) is trading at Rp358.09 with a bearish technical signal, as indicated by moving averages showing 1 buy versus 12 sell signals. The current price is near the pivot point of Rp363, with immediate support at Rp341 and resistance at Rp384. Market cap stands at Rp152.98 million with 43% of the max supply in circulation. No major protocol updates or ecosystem developments have been reported recently, and trading volume remains low.
Overall outlook is cautious due to bearish technical indicators and limited liquidity. Key opportunities include potential rebounds from support levels, but risks involve high volatility, low market cap susceptibility to manipulation, and absence of recent fundamental catalysts. Investors should monitor for any ecosystem updates or exchange listings that could impact liquidity and price stability.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Resolv
Resolv is a protocol that maintains USR, a stablecoin natively backed by Ethereum and Bitcoin, which is pegged to the US Dollar.
Read more on RESOLV →
